Legacy App users can now access the Health Portal – just reset your password using email as username.

Managing Your Own Polycythemia

Managing Your Own Polycythemia

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
The clinician explains how elevated hemoglobin and hematocrit on testosterone should be interpreted with symptoms, blood pressure, and clot history. A clear plan is given to pair CBC trends with iron studies like ferritin and transferrin saturation before deciding on phlebotomy.

Video Summary

Polycythemia is described as an issue many testosterone or steroid users discover after reviewing a CBC panel. The clinician frames elevated hemoglobin and hematocrit as signals that require context, not instant alarm or guessing. Numbers like hemoglobin above roughly 17.5 grams per deciliter are mentioned as a point where people start asking questions. Symptoms are used as the next filter, including headaches or blurry vision that could reflect thicker blood. Cardiovascular context matters too, so blood pressure, cholesterol, and coronary calcium scoring are raised for risk framing. Past events like stroke, heart attack, or heart failure are treated as important history when deciding how aggressive to be. Clot history is also reviewed, because prior leg clots or pulmonary embolism changes the stakes of management choices.

For members managing this themselves, the clinician narrows the plan to two core actions supported by careful lab tracking. First, obtain a CBC that includes hemoglobin and hematocrit, because those values anchor the discussion and trend monitoring. Second, add iron studies, because a high CBC alone is not enough to decide whether blood removal is safe. The lab list is specific, calling out iron, total iron, ferritin, and transferrin saturation for a complete picture. Looking at these together helps identify men whose hematocrit is elevated while iron stores are already low. A ferritin below about 200 is described as a safer zone where phlebotomy may be unnecessary if symptoms are absent. This approach aims to prevent overcorrecting and creating iron depletion while chasing a laboratory target.

When symptoms exist or iron markers suggest overload, the clinician discusses changing drivers rather than repeatedly donating blood. Adjusting testosterone dosing or reducing steroid exposure is presented as a direct lever to lower red cell stimulation. Sleep apnea is highlighted as another modifiable contributor, because untreated breathing disruption can push counts upward. Phlebotomy is positioned as an option when risk is higher, yet it is framed as something that should be done deliberately. Diet is briefly mentioned, including reducing red meat and shifting toward plant based eating to support broader cardiometabolic goals. The presenter invites men to come prepared with both CBC values and iron studies so case by case guidance is possible. The closing message emphasizes using this information alongside personal healthcare providers to make safer decisions.

Drug Callouts

Drug
Description
Testosterone
Testosterone therapy can stimulate erythropoiesis, leading some users to higher hemoglobin and hematocrit on CBC testing. The clinician frames dosing adjustment and careful monitoring as primary tools when red cell elevation becomes concerning.
Anabolic steroids
Anabolic steroids are additional androgenic exposures that may amplify red blood cell production beyond typical replacement dosing. The presenter suggests reducing steroid use when CBC values climb and symptoms or risk history raise concern.

Condition Callouts

Condition
Description
Polycythemia
Polycythemia refers to an elevated red blood cell mass that can increase blood viscosity and strain circulation. The clinician discusses it in the context of hemoglobin and hematocrit elevations seen with testosterone or steroid use.
Hypertension
Hypertension is persistently elevated blood pressure that increases cardiovascular risk and can worsen outcomes when blood viscosity rises. The presenter asks about blood pressure because it helps determine how aggressive management should be.
Heart disease
Heart disease describes coronary or structural cardiac problems that raise the stakes of thrombotic and vascular events. Calcium scoring and cholesterol are mentioned as tools that help place lab elevations into a broader risk profile.
Stroke
Stroke is an acute brain injury from interrupted blood flow or bleeding that can cause sudden neurologic deficits. Prior stroke history is raised as a major factor when evaluating whether elevated hematocrit represents higher danger.
Heart attack
Heart attack is myocardial injury caused by reduced coronary blood flow and can present with chest pain or shortness of breath. The clinician includes prior heart attack history when outlining who should take polycythemia management most seriously.
Heart failure
Heart failure is a syndrome where the heart cannot pump effectively enough to meet the body’s needs, often leading to fatigue and fluid issues. The talk lists heart failure history as a reason to weigh symptoms and labs more cautiously.
Deep vein thrombosis
Deep vein thrombosis is a clot in the leg veins that can cause swelling, pain, and vascular complications. The clinician asks about prior leg clots because that history changes risk tolerance for elevated hemoglobin and hematocrit.
Pulmonary embolism
Pulmonary embolism is a clot that travels to the lungs and can cause chest pain, shortness of breath, and dangerous oxygen impairment. The presenter mentions pulmonary embolism to emphasize why clot history matters beyond the lab number.
Sleep apnea
Sleep apnea is disordered breathing during sleep that lowers oxygen delivery and can drive compensatory red blood cell production. The clinician highlights treating apnea as a way to reduce elevated CBC values without repeated blood removal.
Iron deficiency
Iron deficiency occurs when iron stores fall and can cause fatigue, weakness, and impaired performance even when hemoglobin looks acceptable. The discussion stresses ferritin and transferrin saturation to avoid phlebotomy that unnecessarily depletes iron.

Key Takeaways

  • Elevated hemoglobin and hematocrit on testosterone should be interpreted with symptoms, blood pressure, and clot history.
  • Checking iron studies, including ferritin and transferrin saturation, prevents unnecessary phlebotomy and avoidable iron depletion.
  • Men without symptoms and with lower ferritin are often better served by monitoring trends rather than donating blood reflexively.
  • Adjusting testosterone or steroid exposure and addressing sleep apnea are presented as primary levers to reduce red cell elevation.
  • Preparing CBC and iron results for clinician review supports safer shared decisions with personal healthcare providers.

More Videos